ProvaLabs has been selected for the DeepTech TIPS program as a fast-track corp. The program, which nurtures startups with breakthrough technologies, will provide ProvaLabs with KRW 1.5 billion (approximately $1.12 million) over three years for R&D and commercialization. The selected project focuses on developing a multimodal biosensor system for analyzing retinal organoids, a cutting-edge tool in retinal disease drug development. This selection highlights ProvaLabs’ growing reputation in deep tech innovation.